Abstract
Procalcitonin (PCT) and C-reactive protein (CRP) may be useful to predict complicated forms of malaria. A total of 30 consecutive travelers diagnosed with Plasmodium falciparum malaria over a two-year period were included in the study. Patients with complicated Plasmodium falciparum malaria showed higher levels of parasitemia (P = 0.0001), PCT (P = 0.0018), CRP (P = 0.0005), bilirubinemia (P = 0.004), and a lower platelet count (P<0.0001) compared with patients with uncomplicated forms. PCT levels above 5 ng/mL showed the highest value of specificity (0.86) and positive predictive factor (0.67) among other parameters, and equal sensitivity (0.67) was displayed by CRP levels above 150 mg/dl. None of the patients with complicated malaria showed PCT levels within normal limits (<0.5 ng/ml). Both PCT and CRP correlated with parasitemia (P<0.001) and showed areas under ROC curve of 0.83. At multivariate analysis, only PCT was associated with an increased risk of complicated malaria (OR 8.2, IC 95% 1.2–57.2, P = 0.03). The determination of PCT on admission showed better results compared to CRP, platelet count, and bilirubinemia and can be useful in non-endemic areas for the initial clinical assessment of disease severity in travelers with Plasmodium falciparum malaria.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ansar W., Habib S.K., Roy S., Mandal C., Mandal C. 2009. Unraveling the C-reactive protein complement-cascade in destruction of red blood cells: potential pathological implications in Plasmodium falciparum malaria. Celluar Physiology and Biochemistry, 23, 175–190. DOI: 10.1159/000204106
Anstey N.M., Price R.N. 2007. Improving case definitions for severe malaria. PLoS Medicine, 4:e267 DOI: 10.1371/journal.pmed. 0040267
Bailey J.W., Williams J., Bain B.J., Parker-Williams J., Chiodini P.L. 2013. General Haematology Task Force of the British Committee for Standards in H. Guideline: the laboratory diagnosis of malaria. General Haematology Task Force of the British Committee for Standards in Haematology. Brish Journal of Haematology, 163, 573–580. DOI:10.1111/bjh.12572
Black S., Kushner I., Samols D. 2004 C-reactive Protein. The Journal of Biological Chemistry, 279, 48487–48490. DOI: 10.1074/jbc.r400025200
Braun N., Marfo Y., Von Gartner C., Burchard G.D., Zipfel P.F., Browne N.E.N., Fleischer B., Broker B. 2003. CTLA-4 positive T cells in contrast to procalcitonin plasma levels discriminate between severe and uncomplicated Plasmodium falciparum malaria in Ghanaian children. Tropical Medicine and International Health, 8, 1018–1024. DOI: 10.1046/j.1360-2276.2003.01128.x
Center for Disease Control and Prevention (CDC). 2015. Malaria - Diagnosis and Tratment in the US. Rapid diagnostic tests, https://doi.org/www.cdc.gov/malaria/diagnosis_treatment/rdt.html.
Chiwakata C.B., Manegold C., Bonicke L., Waase I., Julch C., Dietrich M. 2001. Procalcitonin as a parameter of disease severity and risk of mortality in patients with Plasmodium falciparum malaria. Journal of Infectious Diseases, 183, 1161–1164. DOI: 10.1086/319283
Erdman L.K., Dhabangi A., Musoke C., Conroy A.L., Hawkes M., Higgins S., Rajwans N., Wolofsky K.T., Streiner D.L., Liles W.C., Cserti-Gazdewich C.M., Kain K.C. 2011. Combinations of host biomarkers predict mortality among Ugandan children with severe malaria: a retrospective case-control study. PLoS One, 6, e17440. DOI: 10.1371/journal.pone.0017440
Guide for the use of procalcitonin (PCT) in diagnosis and monitoring of sepsis. https://doi.org/www.procalcitonin.com/pct-guide/pdf/2008- 09/PCT_Guide_EN.pdf. April 2008
Hesselink D.A., Burgerhart J.S., Bosmans-Timmerarends H., Petit P., van Genderen P.J. 2009. Procalcitonin as a biomarker for severe Plasmodium falciparum disease: a critical appraisal of a semi-quantitative point-of-care test in a cohort of travellers with imported malaria. Malaria Journal, 8, 206. DOI: 10.1186/1475-2875-8-206
Hurt N., Smith T., Teuscher T., Tanner M. 1994. Do high levels of C-reactive protein in Tanzanian children indicate malaria morbidity. Clinical and Diagnostic Laboratory Immunology, 1, 437–444. DOI: 10.1016/0035-9203(94)90287-9
Marnell L., Mold C., Du Clos T.W. 2005. C-reactive protein: ligands, receptors and role in inflammation. Clinical Immunology, 117, 104–111 DOI: 10.1016/j.clim.2005.08.004
Marsh K., Forster D., Waruiru C., Mwangi I., Winstanley M., Marsh V., Newton C., Winstanley P., Warn P., Peshu N. 1995. Indicators of life-threatening malaria in African children. New England Journal of Medicine, 332, 1399–1404 DOI: 10.1056/ nejm199505253322102
McGuire W., D’Alessandro U., Olaleye B.O., Thomson M.C., Langerock P., Greenwood B.M., Kwiatkowski D. 1996. C-reactive protein and haptoglobin in the evaluation of a communitybased malaria control programme. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 10–14. DOI: 10.1016/s0035-9203(96)90461-7
Simon L., Gauvin F., Amre D.K., Saint-Louis P., Lacroix J. 2004. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clinical Infectious Diseases, 39, 206–217 DOI: 10.1086/421997
Tangpukdee N., Krudsood S., Kano S., Wilairatana P. 2012. Falciparum malaria parasitemia index for predicting severe malaria. International Journal of Laboratory Hematology, 34, 320–327. DOI: 10.1111/j.1751-553X.2011.01398
te Witt R., van Wolfswinkel M.E., Petit P.L., van Hellemond J.J., Koelewijn R., van Belkum A., van Genderen P.J. 2010. Neopterin and procalcitonin are suitable biomarkers for exclusion of severe Plasmodium falciparum disease at the initial clinical assessment of travellers with imported malaria. Malaria Journal, 9, 255. DOI: 10.1186/1475-2875-9-255
van Genderen P.J., van der Meer I.M., Consten J., Petit P.L., van Gool T., Overbosch D. 2005. Evaluation of plasma lactate as a parameter for disease severity on admission in travelers with Plasmodium falciparum malaria. Journal of Travel Medicine, 12, 261–264. DOI: 10.2310/7060.2005.12504
Wacker C., Prkno A., Brunkhorst F.M., Schlattmann P. 2013. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infectious Diseases, 13, 426–435 DOI: 10.1016/s1473-3099(12)70323-7
Walther M., Tongren J.E., Andrews L., et al. 2005. Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity, 23, 287–296. DOI: 10.1016/j.immuni.2005.08.006
World Health Organization. 2000. Severe falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 94, S1–S90. DOI: 10.1016/s0035-9203(00)90300-6
World Health Organization. 2010. Guidelines for the treatment of malaria 2nd edition. Geneva: World Health Organization March 2010, 35
Zhang R., Becnel L., Li M., Chen C., Yao Q. 2006. C-reactive protein impairs human CD14+ monocyte-derived dendritic cell differentiation, maturation and function. European Journal of Immunology, 36, 2993–3006. DOI: 10.1002/eji.200635207
Zhong W., Zen Q., Tebo J., Schlottmann K., Coggeshall M., Mortensen R.F. 1998. Effect of human C-reactive protein on chemokine and chemotactic factor-induced neutrophil chemotaxis and signaling. Journal of Immunology, 161, 2533–2540. DOI: 10.4049/jimmunol.168.3.1413
Author information
Authors and Affiliations
Corresponding author
Additional information
Elda Righi and Maria Merelli contributed equally to this work and should be consider as first co-authors Author’s
Rights and permissions
About this article
Cite this article
Righi, E., Merelli, M., Arzese, A. et al. Determination of PCT on admission is a useful tool for the assessment of disease severity in travelers with imported Plasmodium falciparum malaria. Acta Parasit. 61, 412–418 (2016). https://doi.org/10.1515/ap-2016-0055
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1515/ap-2016-0055